Original ArticlesEvaluation of the Clinical Features, Management, and Prognoses of Patients With Charles Bonnet SyndromeBuyukgol, Huseyin MD*; Ilik, Faik MD*; Ertem, Devrimsel Harika MD†Author Information *Department of Neurology, Faculty of Medicine, KTO Karatay University Medicana, Konya †Department of Neurology, Şişli Hamidiye Etfal Education and Research Hospital, İstanbul, Turkey. Send reprint requests to Huseyin Buyukgol, MD, Department of Neurology, Faculty of Medicine, KTO Karatay University Medicana, Musalla Baglari, Gurz St. No: 1, 42060 Selcuklu/Konya, Turkey. E-mail: firstname.lastname@example.org. Online date: November 8, 2019 The Journal of Nervous and Mental Disease: December 2019 - Volume 207 - Issue 12 - p 1045-1047 doi: 10.1097/NMD.0000000000001101 Buy Metrics Abstract Charles Bonnet syndrome (CBS) is characterized by visual hallucinations with preservation of cognitive abilities. The hallucinations consist mostly of vivid (realistic) objects and tend to reoccur. Here, we evaluate the etiologies, symptoms, treatments, and prognoses of 13 CBS cases. All patients had visual hallucinations but were normal on cognitive and psychiatric assessments. Patient demographic and clinical characteristics, treatment options, and 3-month follow-up data were retrospectively reviewed. The possible causes of CBS and what the patients perceived during their hallucinations were recorded. Antipsychotic agents, such as risperidone and quetiapine, and anticonvulsants, such as levetiracetam, may be effective in some cases. Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.